18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis.
Belhocine
Tarik Z
TZ
Department of Nuclear Medicine, Jules Bordet Cancer Institute, Brussels, Belgium. tarik.bel@swing.be
D002986:Clinical Trials as Topic; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18